Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Relation of the Mediterranean diet with the incidence of gestational diabetes.

Karamanos B, Thanopoulou A, Anastasiou E, Assaad-Khalil S, Albache N, Bachaoui M, Slama CB, El Ghomari H, Jotic A, Lalic N, Lapolla A, Saab C, Marre M, Vassallo J, Savona-Ventura C; MGSD-GDM Study Group.

Eur J Clin Nutr. 2014 Jan;68(1):8-13. doi: 10.1038/ejcn.2013.177. Epub 2013 Oct 2.

PMID:
24084515
[PubMed - in process]
2.

Comment on: Zhu et al. Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China. Diabetes Care 2013;36:2038-2040.

Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD-GDM Study Group.

Diabetes Care. 2013 Sep;36(9):e165. doi: 10.2337/dc13-0936. No abstract available.

PMID:
23970736
[PubMed - indexed for MEDLINE]
3.

Obstetric adiposity in the Mediterranean region.

Savona-Ventura C, Marre M, Vassallo J, Karamanos B; MGSD-GDM study group.

Int J Gynaecol Obstet. 2013 Jul;122(1):80-1. doi: 10.1016/j.ijgo.2013.02.021. Epub 2013 Apr 9. No abstract available.

PMID:
23582644
[PubMed - indexed for MEDLINE]
4.

A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women.

Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD-GDM study group.

Int J Gynaecol Obstet. 2013 Mar;120(3):240-4. doi: 10.1016/j.ijgo.2012.10.016. Epub 2012 Dec 29. Erratum in: Int J Gynaecol Obstet. 2013 Jul;122(1):88. Louda, F [added]; Addi, H [added]; Joubij, M [added]; Chraibi, A [added].

PMID:
23279935
[PubMed - indexed for MEDLINE]
5.

Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.

Soedamah-Muthu SS, Chaturvedi N, Fuller JH, Toeller M; EURODIAB Prospective Complications Study Group.

Eur J Nutr. 2013 Oct;52(7):1701-10. doi: 10.1007/s00394-012-0473-7. Epub 2012 Dec 7.

PMID:
23224030
[PubMed - indexed for MEDLINE]
6.

Hyperglycaemia in pregnancy in Mediterranean women.

Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD:GDM Study Group.

Acta Diabetol. 2012 Dec;49(6):473-80. doi: 10.1007/s00592-012-0427-9. Epub 2012 Sep 1.

PMID:
22941281
[PubMed - indexed for MEDLINE]
7.

Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study.

van Bussel BC, Soedamah-Muthu SS, Henry RM, Schalkwijk CG, Ferreira I, Chaturvedi N, Toeller M, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):758-64. doi: 10.1016/j.numecd.2012.04.005. Epub 2012 Jul 12.

PMID:
22795869
[PubMed - indexed for MEDLINE]
8.

Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study.

Schoenaker DA, Toeller M, Chaturvedi N, Fuller JH, Soedamah-Muthu SS; EURODIAB Prospective Complications Study Group.

Diabetologia. 2012 Aug;55(8):2132-41. doi: 10.1007/s00125-012-2550-0. Epub 2012 Apr 12.

PMID:
22526612
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.

Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Eur J Endocrinol. 2012 Feb;166(2):325-32. doi: 10.1530/EJE-11-0662. Epub 2011 Nov 29.

PMID:
22127490
[PubMed - indexed for MEDLINE]
Free Article
10.

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group.

Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12.

PMID:
21225239
[PubMed - indexed for MEDLINE]
11.

Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA).

Karamanos B, Thanopoulou A, Drossinos V, Charalampidou E, Sourmeli S, Archimandritis A; Hellenic ECLA Study Group.

Curr Med Res Opin. 2011 Feb;27(2):303-13. doi: 10.1185/03007995.2010.542081. Epub 2010 Dec 9.

PMID:
21142615
[PubMed - indexed for MEDLINE]
12.

A hybrid Decision Support System for the risk assessment of retinopathy development as a long term complication of Type 1 Diabetes Mellitus.

Skevofilakas M, Zarkogianni K, Karamanos BG, Nikita KS.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:6713-6. doi: 10.1109/IEMBS.2010.5626245.

PMID:
21096083
[PubMed - indexed for MEDLINE]
13.

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Thanopoulou A, Karamanos B, Archimandritis A.

N Engl J Med. 2010 May 27;362(21):2030-1; author reply 2031. No abstract available.

PMID:
20518103
[PubMed - indexed for MEDLINE]
14.

Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease.

Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, Karamanos B, Manesis E, Archimandritis A.

Hepatol Res. 2009 Oct;39(10):972-8. doi: 10.1111/j.1872-034X.2009.00534.x. Epub 2009 Jul 13.

PMID:
19624771
[PubMed]
15.

Evidence that even "normal" albuminuria may denote incipient GFR reduction in patients with type 2 diabetes mellitus.

Kravaritou M, Thanopoulou A, Karamanos B, Kofinis A, Noutsou M, Spanou E, Varsou A, Archimandritis A.

Diabetes Res Clin Pract. 2009 Sep;85(3):317-21. doi: 10.1016/j.diabres.2009.06.019. Epub 2009 Jul 10.

PMID:
19596469
[PubMed - indexed for MEDLINE]
16.

Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.

Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ.

J Viral Hepat. 2009 Jun;16(6):430-6. doi: 10.1111/j.1365-2893.2009.01077.x. Epub 2009 Feb 6.

PMID:
19200136
[PubMed - indexed for MEDLINE]
17.

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7. Epub 2008 Sep 25.

PMID:
18823658
[PubMed - indexed for MEDLINE]
Free Article
18.

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9. Epub 2008 Sep 25.

PMID:
18823656
[PubMed - indexed for MEDLINE]
19.

Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group.

Diabetes Care. 2008 Jul;31(7):1360-6. doi: 10.2337/dc08-0107. Epub 2008 Mar 28.

PMID:
18375412
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes.

Thanopoulou A, Karamanos B, Angelico F, Assaad-Khalil S, Djordjevic P, Katsilambros N, Migdalis I, Mrabet M, Petkova M, Roussi D, Tenconi MT, Archimandritis A.

Eur J Clin Nutr. 2006 Dec;60(12):1376-83. Epub 2006 Jul 5.

PMID:
16823407
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk